Literature DB >> 18474469

Genital vitiligo-like depigmentation following use of imiquimod 5% cream.

Vasco Vieira Serrão, Filipa Rocha Páris, Ana Barata Feio.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18474469     DOI: 10.1684/ejd.2008.0402

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


× No keyword cloud information.
  7 in total

1.  Epidermal permeability barrier recovery is delayed in vitiligo-involved sites.

Authors:  J Liu; W Y Man; C Z Lv; S P Song; Y J Shi; P M Elias; M Q Man
Journal:  Skin Pharmacol Physiol       Date:  2010-02-25       Impact factor: 3.479

2.  Development of Vitiligo-Like Depigmentation after Treatment of Lentigo Maligna Melanoma with 5% Imiquimod Cream.

Authors:  Na Hee Kim; Jee Bum Lee; Sook Jung Yun
Journal:  Ann Dermatol       Date:  2018-06-28       Impact factor: 1.444

3.  Pilot study examining the combined use of pulsed dye laser and topical Imiquimod versus laser alone for treatment of port wine stain birthmarks.

Authors:  Cheng-Jen Chang; Yen-Chang Hsiao; Martin C Mihm; J Stuart Nelson
Journal:  Lasers Surg Med       Date:  2008-11       Impact factor: 4.025

4.  Wart with depigmented halo and generalized vitiligo.

Authors:  Takamichi Ito; Yuichi Yoshida; Koji Adachi; Masutaka Furue; Osamu Yamamoto
Journal:  Yonago Acta Med       Date:  2012-12-06       Impact factor: 1.641

5.  Genital vitiligo following use of imiquimod 5% cream.

Authors:  Ruzhi Zhang; Wenyuan Zhu
Journal:  Indian J Dermatol       Date:  2011-05       Impact factor: 1.494

6.  Induction of vitiligo after imiquimod treatment of condylomata acuminata.

Authors:  Wenfei Li; Hongyan Xin; Lingzhi Ge; Haiyan Song; Wang Cao
Journal:  BMC Infect Dis       Date:  2014-06-13       Impact factor: 3.090

7.  Transcriptome analysis reveals markers of aberrantly activated innate immunity in vitiligo lesional and non-lesional skin.

Authors:  Richard Yu; Raewyn Broady; Yuanshen Huang; Yang Wang; Jie Yu; Min Gao; Megan Levings; Shencai Wei; Shengquan Zhang; Aie Xu; Mingwan Su; Jan Dutz; Xuejun Zhang; Youwen Zhou
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.